Zura Bio LimitedLong
ZURA - Upcoming Catalysts coming
Mis à jour
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Disclaimer: This document is for informational purposes only and is not intended as financial advice. Please consult with a financial advisor before making any investment decisions.
Investment Overview (As of April 27, 2024)
Shares Information:
Shares Float: 18.9 Million
Relative Volume (Rel. Vol): 3.08
Insider Activity:
Recent insider purchases noted, indicating potential confidence in the company’s future.
Upcoming Corporate Events:
Clinical Trials: Five trials scheduled for 2024.
Financial Health:
Strong liquidity position with substantial cash reserves and minimal debt.
Key Technical Levels:
Resistance Levels: Watch for $5.30, $6.30, $7.50, and $8.70. These points may offer opportunities for taking partial profits.
Trading Strategy:
Take Profit (TP): Set a profit target at approximately $11.00 to capitalize on earnings.
Stop Loss (SL): Establish a stop loss order below $4.00 to limit potential losses.
Chart Analysis:
For a comprehensive analysis of price actions and trends, refer to the attached chart.
Risk Advisory:
Investing involves substantial risks. It is crucial to evaluate market conditions and your personal risk tolerance carefully. Conduct thorough research or consult with a financial advisor before making any trading decisions.
Disclaimer: This document is for informational purposes only and is not intended as financial advice. Please consult with a financial advisor before making any investment decisions.
Investment Overview (As of April 27, 2024)
Shares Information:
Shares Float: 18.9 Million
Relative Volume (Rel. Vol): 3.08
Insider Activity:
Recent insider purchases noted, indicating potential confidence in the company’s future.
Upcoming Corporate Events:
Clinical Trials: Five trials scheduled for 2024.
Financial Health:
Strong liquidity position with substantial cash reserves and minimal debt.
Key Technical Levels:
Resistance Levels: Watch for $5.30, $6.30, $7.50, and $8.70. These points may offer opportunities for taking partial profits.
Trading Strategy:
Take Profit (TP): Set a profit target at approximately $11.00 to capitalize on earnings.
Stop Loss (SL): Establish a stop loss order below $4.00 to limit potential losses.
Chart Analysis:
For a comprehensive analysis of price actions and trends, refer to the attached chart.
Risk Advisory:
Investing involves substantial risks. It is crucial to evaluate market conditions and your personal risk tolerance carefully. Conduct thorough research or consult with a financial advisor before making any trading decisions.
Note
hit 6.35Note
Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC FilingMay 23, 202416:00 GMT+2
Join Discord channel:
whop.com/marketplace/contingent-traders/
contingenttrader.com/
whop.com/marketplace/contingent-traders/
contingenttrader.com/
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.